<DOC>
	<DOC>NCT01466244</DOC>
	<brief_summary>RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors predict how well patients will respond to treatment. PURPOSE: This research study is studying biomarkers in patients with metastatic or recurrent head and neck cancer treated with cisplatin and cetuximab on ECOG-E5397.</brief_summary>
	<brief_title>Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397</brief_title>
	<detailed_description>OBJECTIVES: Primary - Compare cetuximab activity, as reflected in response rate (RR), in PTEN-deficient and PTEN-expressing cancers. Secondary - Examine RR, progression-free survival (PFS), and overall survival (OS) in PTEN-deficient and PTEN-expressing cancers, by treatment arm. OUTLINE: Tissue microarray slides collected earlier from ECOG-E5397 are immunostained with PTEN antibody and analyzed with AQUA.</detailed_description>
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>DISEASE CHARACTERISTICS: Treated on protocol ECOGE5397 PATIENT CHARACTERISTICS: Not specified PRIOR CONCURRENT THERAPY: See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>metastatic squamous neck cancer with occult primary squamous cell carcinoma</keyword>
	<keyword>recurrent metastatic squamous neck cancer with occult primary</keyword>
	<keyword>recurrent squamous cell carcinoma of the hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma of the larynx</keyword>
	<keyword>recurrent squamous cell carcinoma of the lip and oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma of the oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage III squamous cell carcinoma of the hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma of the larynx</keyword>
	<keyword>stage III squamous cell carcinoma of the lip and oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma of the oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage IVA squamous cell carcinoma of the larynx</keyword>
	<keyword>stage IVA squamous cell carcinoma of the lip and oral cavity</keyword>
	<keyword>stage IVA squamous cell carcinoma of the oropharynx</keyword>
	<keyword>stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage IVB squamous cell carcinoma of the larynx</keyword>
	<keyword>stage IVB squamous cell carcinoma of the lip and oral cavity</keyword>
	<keyword>stage IVB squamous cell carcinoma of the oropharynx</keyword>
	<keyword>stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage IVC squamous cell carcinoma of the larynx</keyword>
	<keyword>stage IVC squamous cell carcinoma of the lip and oral cavity</keyword>
	<keyword>stage IVC squamous cell carcinoma of the oropharynx</keyword>
	<keyword>stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>untreated metastatic squamous neck cancer with occult primary</keyword>
</DOC>